Enhancement of solubility and dissolution rate of domperidone by utilizing different techniques.

Research Authors
E. H. Ibrahim, T. H. El-Faham, F.A. Mohammed and N. S. El-Eraky,
Research Department
Department of Pharmaceutics
Research Journal
Bull. Pharm. Sci., Assiut University,
Research Member
Nermin Elsayed Ali Mohamed Elsayed Eliraqi
Research Rank
2
Research Vol
105-120
Research Year
2011

Enhancement of solubility and dissolution rate of domperidone by utilizing different techniques.

Research Authors
E. H. Ibrahim, T. H. El-Faham, F.A. Mohammed and N. S. El-Eraky,
Research Department
Department of Pharmaceutics
Research Journal
Bull. Pharm. Sci., Assiut University,
Research Member
Fergany Abdul Hameed Mohamed El-Gamal
Research Rank
2
Research Vol
105-120
Research Year
2011

Evaluation of a Novel Vaginal Bromocriptine Mesylate Formulation: A Pilot Study.

Research Abstract
Because of the frequent side effects found with oral bromocriptine, we created two formulas of vaginal bromocriptine suppositories to compare with vaginal application of bromocriptine tablets. The formula containing bromocriptine and a releasing agent (Pluronic F127) showed an increased dissolution rate, 39-fold greater than that of the pure drug alone, and subsequently was effective in lowering serum prolactin.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El- Gebali, Sahar B. Hassan.,
Research Department
Department of Pharmaceutics
Research Journal
Fertility and Sterility
Research Member
Ehsan Hafiz Ibrahim Abdel-Latif
Research Rank
1
Research Vol
83 (4),
Research Website
http://www.researchgate.net/publication/7915608_Evaluation_of_a_novel_vaginal_bromocriptine_mesylate_formulation_a_pilot_study
Research Year
2005

Evaluation of a Novel Vaginal Bromocriptine Mesylate Formulation: A Pilot Study.

Research Abstract
Because of the frequent side effects found with oral bromocriptine, we created two formulas of vaginal bromocriptine suppositories to compare with vaginal application of bromocriptine tablets. The formula containing bromocriptine and a releasing agent (Pluronic F127) showed an increased dissolution rate, 39-fold greater than that of the pure drug alone, and subsequently was effective in lowering serum prolactin.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El- Gebali, Sahar B. Hassan.,
Research Department
Department of Pharmaceutics
Research Journal
Fertility and Sterility
Research Member
Ibrahim Elsayed El-Gibaly Khudair
Research Rank
1
Research Vol
83 (4),
Research Website
http://www.researchgate.net/publication/7915608_Evaluation_of_a_novel_vaginal_bromocriptine_mesylate_formulation_a_pilot_study
Research Year
2005

Evaluation of a Novel Vaginal Bromocriptine Mesylate Formulation: A Pilot Study.

Research Abstract
Because of the frequent side effects found with oral bromocriptine, we created two formulas of vaginal bromocriptine suppositories to compare with vaginal application of bromocriptine tablets. The formula containing bromocriptine and a releasing agent (Pluronic F127) showed an increased dissolution rate, 39-fold greater than that of the pure drug alone, and subsequently was effective in lowering serum prolactin.
Research Authors
Atef M. Darwish, Ehsan Hafez, Ibraheem El- Gebali, Sahar B. Hassan.,
Research Journal
Fertility and Sterility
Research Rank
1
Research Vol
83 (4),
Research Website
http://www.researchgate.net/publication/7915608_Evaluation_of_a_novel_vaginal_bromocriptine_mesylate_formulation_a_pilot_study
Research Year
2005
Subscribe to